Deals

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery
Atavistik BioOTCMKTS: RHHBY

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery

Atavistik Bio announced a strategic research collaboration with Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) to discover and develop novel small molecule therapies targeting multiple targets in cardiovascular, renal, and…

Neurorevix Completes Tens of Millions RMB Angel Round Led by HSG – BCI and Neuromodulation Pioneer Advances "Closed‑Loop Nerve Bundle Modulation" Platform

Neurorevix Completes Tens of Millions RMB Angel Round Led by HSG – BCI and Neuromodulation Pioneer Advances “Closed‑Loop Nerve Bundle Modulation” Platform

Boehringer Ingelheim and WHO Foundation Launch Three‑Year, USD 5 Million Collaboration to Tackle Obesity in Resource‑Limited Settings

Boehringer Ingelheim and WHO Foundation Launch Three‑Year, USD 5 Million Collaboration to Tackle Obesity in Resource‑Limited Settings

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
WuXi XDC Partners with MABSOFT to Advance Innovative ADC Development
ADC / XDCHKG: 2268

WuXi XDC Partners with MABSOFT to Advance Innovative ADC Development

Pfizer and Flagship Pioneering Collaborate on AI-Driven Drug Development
AIFlagship Pioneering

Pfizer and Flagship Pioneering Collaborate on AI-Driven Drug Development

Nurix Therapeutics Expands Sanofi Partnership with Undisclosed TPD Program
EPA: SANNASDAQ: NRIX

Nurix Therapeutics Expands Sanofi Partnership with Undisclosed TPD Program

Organon Acquires U.S. Rights to TOFIDENCE from Biogen
BiogenBiosimilars

Organon Acquires U.S. Rights to TOFIDENCE from Biogen

Show More